Rimona Margalit

11.5k total citations · 1 hit paper
67 papers, 9.4k citations indexed

About

Rimona Margalit is a scholar working on Molecular Biology, Materials Chemistry and Cell Biology. According to data from OpenAlex, Rimona Margalit has authored 67 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 14 papers in Materials Chemistry and 13 papers in Cell Biology. Recurrent topics in Rimona Margalit's work include Porphyrin and Phthalocyanine Chemistry (13 papers), Protein Interaction Studies and Fluorescence Analysis (8 papers) and Lipid Membrane Structure and Behavior (8 papers). Rimona Margalit is often cited by papers focused on Porphyrin and Phthalocyanine Chemistry (13 papers), Protein Interaction Studies and Fluorescence Analysis (8 papers) and Lipid Membrane Structure and Behavior (8 papers). Rimona Margalit collaborates with scholars based in Israel, United States and Sweden. Rimona Margalit's co-authors include Dan Peer, Róbert Langer, Seungpyo Hong, Omid C. Farokhzad, Jeffrey M. Karp, Abel Schejter, Smadar Cohen, Michal Rotenberg, Noga Yerushalmi and Nurith Shaklai and has published in prestigious journals such as Nature Nanotechnology, Biomaterials and Biochemistry.

In The Last Decade

Rimona Margalit

67 papers receiving 9.2k citations

Hit Papers

Nanocarriers as an emerging platform for cancer therapy 2007 2026 2013 2019 2007 2.0k 4.0k 6.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rimona Margalit Israel 30 4.6k 3.9k 3.9k 1.9k 776 67 9.4k
Victor C. Yang United States 52 3.5k 0.8× 3.0k 0.8× 4.2k 1.1× 1.2k 0.7× 492 0.6× 222 9.9k
Seulki Lee South Korea 59 4.0k 0.9× 4.3k 1.1× 5.2k 1.3× 2.4k 1.3× 846 1.1× 165 12.0k
A. Christy Hunter United Kingdom 36 4.3k 0.9× 2.9k 0.7× 4.3k 1.1× 1.5k 0.8× 648 0.8× 90 9.6k
Heebeom Koo South Korea 52 3.5k 0.8× 4.6k 1.2× 3.6k 0.9× 1.9k 1.0× 1.2k 1.5× 119 9.2k
Khaled Greish Bahrain 41 3.2k 0.7× 2.8k 0.7× 3.2k 0.8× 1.2k 0.7× 583 0.8× 108 7.4k
Hideaki Nakamura Japan 31 3.6k 0.8× 3.5k 0.9× 2.8k 0.7× 1.1k 0.6× 536 0.7× 94 7.3k
Seo Young Jeong South Korea 62 6.4k 1.4× 4.3k 1.1× 4.8k 1.2× 1.5k 0.8× 2.2k 2.8× 195 13.3k
Elvin Blanco United States 33 4.4k 1.0× 4.0k 1.0× 3.4k 0.9× 1.5k 0.8× 681 0.9× 61 8.9k
Haifa Shen United States 46 4.4k 1.0× 4.4k 1.1× 5.6k 1.4× 1.7k 0.9× 406 0.5× 125 11.6k
Francesco M. Veronese Italy 45 3.4k 0.7× 1.8k 0.4× 5.0k 1.3× 972 0.5× 2.3k 2.9× 168 10.9k

Countries citing papers authored by Rimona Margalit

Since Specialization
Citations

This map shows the geographic impact of Rimona Margalit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rimona Margalit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rimona Margalit more than expected).

Fields of papers citing papers by Rimona Margalit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rimona Margalit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rimona Margalit. The network helps show where Rimona Margalit may publish in the future.

Co-authorship network of co-authors of Rimona Margalit

This figure shows the co-authorship network connecting the top 25 collaborators of Rimona Margalit. A scholar is included among the top collaborators of Rimona Margalit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rimona Margalit. Rimona Margalit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eisenkraft, Arik, et al.. (2016). Treatment of respiratory damage in mice by aerosols of drug-encapsulating targeted lipid-based particles. Journal of Controlled Release. 257. 163–169. 8 indexed citations
2.
Cohen, Keren, et al.. (2013). Cancer cell sensitization and improved treatment efficacy by combined sodium butyrate and paclitaxel formulations is cancer-type specific. International Journal of Pharmaceutics. 461(1-2). 437–447. 5 indexed citations
3.
Zor, Tsaffrir, et al.. (2011). Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response. Journal of Controlled Release. 160(2). 388–393. 33 indexed citations
4.
Batra, Satish, et al.. (2010). Novel steroid carbamates reverse multidrug-resistance in cancer therapy and show linkage among efficacy, loci of drug action and P-glycoprotein's cellular localization. European Journal of Pharmaceutical Sciences. 41(1). 53–59. 14 indexed citations
5.
Cohen, Keren, et al.. (2010). Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials. 31(27). 7106–7114. 120 indexed citations
6.
Dekel, Yoram, et al.. (2010). Novel fibrillar insulin formulations for oral administration: Formulation and in vivo studies in diabetic mice. Journal of Controlled Release. 143(1). 128–135. 16 indexed citations
7.
Margalit, Rimona, et al.. (2009). A color discriminating broad range cell staining technology for early detection of cell transformation. Journal of Carcinogenesis. 8(1). 16–16. 11 indexed citations
9.
Margalit, Rimona, et al.. (2008). Cyclooxygenase inhibition by diclofenac formulated in bioadhesive carriers. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1778(4). 931–936. 19 indexed citations
10.
Biton, Inbal, et al.. (2008). A novel Diclofenac-carrier for local treatment of osteoarthritis applying live-animal MRI. Journal of Controlled Release. 135(1). 65–70. 33 indexed citations
11.
Peer, Dan, Jeffrey M. Karp, Seungpyo Hong, et al.. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology. 2(12). 751–760. 7031 indexed citations breakdown →
12.
Peer, Dan & Rimona Margalit. (2005). Fluoxetine and reversal of multidrug resistance. Cancer Letters. 237(2). 180–187. 61 indexed citations
14.
Peer, Dan, Anat Florentin, & Rimona Margalit. (2003). Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1612(1). 76–82. 76 indexed citations
15.
Peer, Dan & Rimona Margalit. (2000). Physicochemical Evaluation of a Stability-Driven Approach to Drug Entrapment in Regular and in Surface-Modified Liposomes. Archives of Biochemistry and Biophysics. 383(2). 185–190. 36 indexed citations
16.
Yerushalmi, Noga & Rimona Margalit. (1998). Hyaluronic Acid-Modified Bioadhesive Liposomes as Local Drug Depots: Effects of Cellular and Fluid Dynamics on Liposome Retention at Target Sites. Archives of Biochemistry and Biophysics. 349(1). 21–26. 43 indexed citations
17.
Margalit, Rimona, et al.. (1997). Liposome-Encapsulated Ampicillin: Physicochemical and Antibacterial Properties. Journal of Pharmaceutical Sciences. 86(5). 635–641. 38 indexed citations
18.
Yerushalmi, Noga & Rimona Margalit. (1994). Bioadhesive, collagen-modified liposomes: molecular and cellular level studies on the kinetics of drug release and on binding to cell monolayers. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1189(1). 13–20. 29 indexed citations
20.
Schejter, Abel, et al.. (1975). LIGAND‐BINDING REACTIONS AND OXIDATION‐REDUCTION EQUILIBRIA OF CYTOCHROME C. Annals of the New York Academy of Sciences. 244(1). 51–59. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026